Suchergebnisse - "Buti, Maria"

PubPharm (28)

1

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Marcellin, P. | Wong, D. | Sievert, W. | +14

2

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Fung, S. | Gordon, S. | Krastev, Z. | +16

3

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

enthalten in: Journal of hepatology | 2015

von Papatheodoridis, G. | Dalekos, G. | Yurdaydin, C. | +17

4

Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B

enthalten in: Digestive diseases and sciences | 2015

von Tsai, N. | Marcellin, P. | Buti, M. | +10

5

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

enthalten in: Journal of hepatology | 2014

von Marcellin, P. | Buti, M. | Krastev, Z. | +14

6

Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing : Resolving the nitty-gritty

enthalten in: Hepatology (Baltimore, Md.) | 2014

von Rodriguez-Frias, F. | Frias, F. | Tabernero, D. | +2

ErratumIn: Hepatology. 2014 Sep;60(3):1117 Frias, Francisco-Rodriguez [corrected to Rodriguez-Frias, Francisco]

7

HBeAg-positive chronic hepatitis B : why do i treat my patients with Nucleos(t)ide analogs?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2014

von Buti, M.

8

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B : a 5-year open-label follow-up study

enthalten in: Lancet (London, England) | 2013

von Marcellin, P. | Gane, E. | Buti, M. | +12

CommentIn: Lancet. 2013 Feb 9;381(9865):433-4. - PMID 23234726

9

Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review

enthalten in: PharmacoEconomics | 2013

von Buti, M. | Oyagüez, I. | Lozano, V. | +1

10

Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs

enthalten in: Expert review of gastroenterology & hepatology | 2012

von Petersen, J. | Buti, M.